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Abstract
Background: Few studies have defined alternate pathways by which chronic kidney disease (CKD) patients
transition into end-stage renal disease (ESRD).
Methods: We studied all consecutive patients initiated on maintenance hemodialysis or peritoneal dialysis over
several years at two dialysis units in Northern California. Rapid decline in kidney function was considered to have
occurred if a patient was documented to have estimated GFR > 30 ml/min/1.73 m
2 within three months prior to
the initiation of chronic dialysis.
Results: We found that 8 out of 105 incident chronic dialysis patients one dialysis unit (7.6%; 95% confidence
interval 3.4-14.5%) and 9 out of 71 incident patients at another (12.7%, 95% CI 6.0%-22.7%) suffered rapid decline in
kidney function that was the immediate precipitant for the need for permanent renal replacement therapy. All
these patients started hemodialysis and all relied on catheters for vascular access. Documentation submitted to
United States Renal Data System did not fully reflect the health status of these patients during their “pre-ESRD”
period.
Conclusions: A sizeable minority of ESRD cases are preceded by rapid declines in kidney function. The importance
of these periods of rapid decline may have been under-appreciated in prior studies of the natural history of CKD
and ESRD.
Background
Although there is a large body of epidemiology literature
on patients with end-stage renal disease (ESRD)–and in
the past decade, also on patients with chronic kidney
disease (CKD)–relatively few studies have focused on
the transition from CKD to ESRD. We hypothesize
based on our clinical experience that in a sizable minor-
ity of incident ESRD patients develop ESRD after suffer-
ing period of rapid loss of glomerular filtration rate
(GFR) which may or may not fit the current definition
of acute kidney injury (abrupt rise in serum creatinine
of ≥0.3 mg/dl or ≥50% within 48 hours)[1]. This has a
number of clinical and policy implications which we
believe deserve consideration.
The purpose of this study is to quantify the frequency
with which chronic dialysis was precipitated by periods
of rapid decline in kidney function at two dialysis units
in Northern California, USA.
Methods
We conducted a retrospective chart review study at two
outpatient chronic dialysis units in San Francisco,
California, USA. The study population consisted of
consecutive patients initiated on chronic maintenance
dialysis between October 2005 and December 2007 at
California Pacific Medical Center (CPMC) Pacific Cam-
p u so u t p a t i e n td i a l y s i su n i ta sw e l la sc o n s e c u t i v e
patients initiated between January 2005 to December
2009 at San Francisco Veterans Affairs Medical Center
(SFVAMC). CPMC is a private, not-for-profit medical cen-
ter in San Francisco, California. SFVAMC is one of the
three major teaching hospitals affiliated with University
of California, San Francisco. Patients initiated on
either chronic hemodialysis or peritoneal dialysis were
included.
Medical records were reviewed to determine the frac-
tion of patients whose ESRD was immediately preceded
by periods of rapid decline in kidney function. Rapid
decline in kidney function was considered to have
occurred if a patient was documented to have estimated
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2 within three months prior to
the initiation of chronic dialysis. GFR was estimated
using the 4-variable Modification of Diet in Renal Dis-
ease (MDRD) equation [2,3]. We chose the MDRD
equation because it was developed in a CKD population
with a range of GFR similar to the range of GFR prior
to ESRD we expected to examine [2].
We reviewed the preceding renal function trajectory (for
up to 2 years prior to ESRD) for those patients meeting
criteria for rapid decline in kidney function. All serum
creatinine values available from the CPMC and the
SFVAMC electronic laboratory databases were abstracted.
In addition, for the patients who suffered rapid decline in
kidney function, individual medical charts were reviewed
in depth by an attending nephrologist (KJ or CYH) to
determine the cause of the rapid decline. Hospital admis-
sion, discharge, and progress notes, as well as consultation
reports, laboratory tests and imaging studies were
reviewed as needed. Particular attention was paid to the
etiology of rapid decline as determined by the attending
nephrologist who cared for the patient.
For the CPMC patients, we also compared informa-
tion abstracted from the medical record with that docu-
mented on the Medical Evidence (CMS 2728) Form,
which is required of all new maintenance dialysis
patients in the USA. This information was not accessible
to researchers at the SFVAMC.
The study was approved by the local Institutional
Review Boards. Because of the low risk nature of the
study, individual patient consent was waived.
Results
Between October 2005 and December 2007, there were
105 incident chronic dialysis patients at CPMC. We
found that among them, 8 (7.6%; 95% confidence inter-
val 3.4-14.5%) suffered rapid decline in kidney function
that was the immediate precipitant for the need for per-
manent renal replacement therapy. The renal trajec-
tories of these 8 patients prior to ESRD are shown in
Figure 1. Mean baseline estimated GFR prior to the
r a p i dd e c l i n e( d e f i n e da st h eh i g h e s tG F Rw i t h i n3
months) was 48.3 ± 12.3 ml/min/1.73 m
2 for these 8
patients.
Between January 2005 to December 2009, there were
71 incident chronic dialysis patients at SFVAMC. We
found that among them, 9 (12.7%, 95% confidence inter-
val 6.0%-22.7%) suffered rapid decline in kidney function
that was the immediate precipitant for the need for per-
manent renal replacement therapy. The renal trajec-
tories of these 9 patients prior to ESRD are shown in
Figure 2. (The patients who were initiated with relatively
higher estimated GFR required dialysis for volume con-
trol [e.g. cardiorenal physiology].) Mean baseline esti-
mated GFR prior to the rapid decline was 50.6 ± 16.1
ml/min/1.73 m
2 for these 9 patients.
Table 1 and 2 show the characteristics of the ESRD
patients whose ESRD was immediately preceded by
rapid decline in kidney function compared with those
whose ESRD was not. Those who developed ESRD
immediately preceded by rapid decline in kidney func-
tion were all treated with hemodialysis and all had to
Figure 1 Renal trajectory for the 8 ESRD cases immediately preceded by ARF from California Pacific Medical Center.
Lee et al. BMC Nephrology 2011, 12:5
http://www.biomedcentral.com/1471-2369/12/5
Page 2 of 7Figure 2 Renal trajectory for the 9 ESRD cases immediately preceded by ARF from San Francisco Veterans Affairs Medical Center.
Table 1 California Pacific Medical Center patient
characteristics
ESRD precipitated
by ARF (N = 8)
ESRD not
precipitated by ARF
(N = 97)
Age at dialysis
initiation (yrs)
69.9 ± 19.2 66.9 ± 13.5
Male 4 (50%) 49 (50.5%)
Race/Ethnicity, N (%)
White 3 (37.5%) 44 (45.3%)
Asian 5 (62.5%) 30 (30.9%)
Black 0 21 (21.6%)
Hispanic 0 2 (2.1%)
Co-morbid conditions,
N (%)
Hypertension 6 (75%) 85 (87.6%)
Diabetes mellitus 4 (50%) 41 (42.2%)
Congestive heart
failure
1 (12.5%) 20 (20.6%)
Initial renal replacement
therapy modality, N (%)
Hemodialysis 8 (100%) 92 (94.8%)
Peritoneal dialysis
(PD)
0 5 (5.2%)*
Access for dialysis, N (%)
Hemodialysis catheter 8 (100%) 69 (71.1%)¶
Hemodialysis fistula 0 22 (22.7%)
Hemodialysis graft 0 1 (1.0%)
Peritoneal dialysis
catheter
0 5 (5.2%)
* p = 0.67 (Fisher’s exact test).
¶ p = 0.33 (Fisher’s exact test).
Table 2 San Francisco Veterans Affairs Medical Center
patient characteristics
ESRD precipitated
by ARF (N = 9)
ESRD not
precipitated by ARF
(N = 62)
Age at dialysis
initiation (yrs)
69.7 ± 10.5 67.3 ± 12.2
Male 9 (100%) 58 (93.5%)
Race/Ethnicity, N (%)
White 2 (22.2%) 27 (43.5%)
Asian 1 (11.1%) 13 (20.9%)
Black 6 (66.7%) 22 (35.5%)
Hispanic 0 0
Co-morbid conditions,
N (%)
Hypertension 9 (100%) 56 (90.3%)
Diabetes mellitus 5 (55.6%) 35 (56.5%)
Congestive heart
failure
1 (11.1%) 24 (38.7%)
Initial renal replacement
therapy modality, N (%)
Hemodialysis 9 (100%) 62 (100%)
Peritoneal dialysis
(PD)
00
Access for dialysis, N (%)
Hemodialysis catheter 9 (100%) 48 (77.4%)§
Hemodialysis fistula 0 12 (19.3%)
Hemodialysis graft 0 2 (3.2%)
Peritoneal dialysis
catheter
00
§ p = 0.50 (Fisher’s exact test).
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of the incident ESRD cases not precipitated by rapid
decline in kidney function at CPMC, 5.2% patients
started peritoneal dialysis and approximately a quarter
had mature arteriovenous fistulas. At SFVAMC, 19.3%
of the incident ESRD patients who did not experience
prior rapid decline in kidney function had fistulas, 3.2%
of patients had grafts.
The etiologies of the rapid decline in kidney function
leading to ESRD–as determined by retrospective chart
review by the study investigators–are shown in Tables 3
and 4. Among the 8 patients at CPMC whose ESRD was
precipitated by rapid decline in kidney function, the
etiology of ESRD listed in the Medical Evidence Form
suggested the acute component in 6 (such as cholesterol
emboli, hemolytic-uremic syndrome, glomerulonephritis
and acute tubular necrosis). In the remaining 2 patients,
it was not possible to discern that there was an acute
component to their disease trajectory (since only dia-
betes mellitus was listed)(Table 3).
Finally, based on data from CPMC, we found that the
documented hemoglobin and albumin levels in
the Medical Evidence Form reflected values observed at
the start of acute dialysis and not values when the
patients were in their usual “baseline” state of health
prior to rapid decline in kidney function (Table 5).
Discussion and Conclusion
In this study of consecutive patients initiated on dialysis
at two San Francisco outpatient dialysis units, we found
there was a period of rapid decline in kidney function
prior to the need for permanent dialysis for 7.6% of
patients at one unit and 12.7% of patients at another.
All patients who started chronic dialysis precipitated by
rapid decline in kidney function started hemodialysis
and all relied on catheters as access. For these patients,
the “primary etiology” of ESRD recorded on the ESRD
Medical Evidence (CMS 2728) Form, such as diabetes
mellitus, sometimes did not capture the critical role of
this acute episode in precipitating the need for ESRD
therapy. Furthermore, the creatinine and hemoglobin
values documented in the Medical Evidence form did
not fully capture the clinical status of these patients dur-
ing their “pre-ESRD” period.
Few prior studies have taken our study approach and
examined relatively abrupt transitions to ESRD at the
individual-patient level [4,5]. Although our results are
based on a relatively small number of patients from two
hospital-affiliated dialysis units, we believe that our
results have face validity and are consistent with the
clinical experience of practicing nephrologists. Our
results are also consistent with that reported by Bhan-
dari and Turney, who found that from 1984 to 1995,
survivors of “acute renal failure” who did not regain
renal function comprised 18.4% of all new patients
taken into their long-term dialysis program in England
[4]. They are also consistent with the high rates of non-
recovery of renal function following dialysis requiring
acute kidney injury which have been reported among
patients ware critically ill [6] or who have pre-existing
chronic kidney disease [7].
We believe that these findings should stimulate think-
ing along several lines. First, periods of rapid loss of
renal function appear to be a prominent feature of the
Table 3 Cause of ESRD as determined by chart review (vs. as reported in the Medical Evidence Form) among California
Pacific Medical Center patients
Patient Cause as determined by chart review Documented cause reported on Medical Evidence Form
1 Cholesterol emboli Cholesterol emboli
2 Hemolytic uremic syndrome Hemolytic uremic syndrome
3 Acute tubular necrosis Type 2 diabetes mellitus
4 Polyarteritis Polyarteritis
5 Cholesterol emboli Type 2 diabetes mellitus
6 Cyclosporine toxicity Complications of transplanted heart
7 Gemcitabine toxicity Tubular necrosis
8 Cholesterol emboli Cholesterol emboli
Table 4 Cause of ESRD as determined by chart review
among San Francisco Veterans Affairs Medical Center
patients
Patient Cause as determined by chart review
1 Acute tubular necrosis
2 Acute tubular necrosis
3 Acute tubular necrosis
4 Unable to determine
5 Acute tubular necrosis
6 Acute tubular necrosis
7 Acute tubular necrosis
8 Acute tubular necrosis
9 Acute tubular necrosis
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patients who develop ESRD. For example, Patient 1 at
CPMC had a decline in estimated GFR from 69 ml/min/
1.73 m
2 to ESRD within a two-month period due to
cholesterol emboli. More research is needed to investi-
gate whether other CKD patients (e.g., those who did
not develop ESRD in the short run) also experience
these periods of rapid decline in renal function as part
of the natural history of their disease.
Second, patients who start chronic dialysis as a result
of rapid loss of kidney function over a short period of
time will naturally have little, if any, opportunity to be
educated about dialysis modality choices or undergo
adequate preparation for dialysis such as pre-emptive
creation of an arteriovenous fistula. Hence, it is not sur-
prising that we observed that 100% of all ESRD cases
preceded by rapid decline in kidney function were
initiated on hemodialysis via a catheter. These consid-
erations suggest that national policy targets such as that
set by “Fistula First” in the USA must take into account
the proportion of new dialysis patients whose ESRD was
precipitated by rapid decline in kidney function. For
example, one of the original clinical performance mea-
sures in the Center for Medicare & Medicaid Services
ESRD US Clinical Performance Measures project was: “A
primary arterial venous fistula should be the access for at
least 50% of all new patients initiating hemodialysis [8].”
We would suggest that the proportion of patients who
started dialysis immediately precipitated by these rapid
declines in kidney function should be removed from the
numerator (and denominator) of such targets. In other
words, the fact that some patients suffer rapid loss of kid-
ney function and transition abruptly from mild-to-mod-
erate CKD to dialysis-dependency must be taken into
consideration when establishing appropriate clinical per-
formance measures for incident dialysis patients. These
patients will also likely not be evaluated for pre-emptive
kidney transplantation.
Table 5 Comparison of laboratory values before and during acute renal failure among California Pacific Medical
Center patients
Patient 3 Months Prior to Dialysis Immediately preceding start of dialysis Recorded on 2728 Form
1 Creatinine (mg/dl) 1.1 15.1 15.1
Albumin (g/dl) 3.8 2.7 2.7
Hemoglobin (g/dl) 13.8 11.9 11.9
2 Creatinine (mg/dl) 1.3 5.9 5.9
Albumin (g/dl) 3.8 3.0 N/A
Hemoglobin (g/dl) 9.9 10.3 10.3
3 Creatinine (mg/dl) 1.0 6.0 6.0
Albumin (g/dl) 3.8 3.6 3.2
Hemoglobin (g/dl) 11.9 10.0 10.0
4 Creatinine (mg/dl) 1.7 7.9 7.9
Albumin (g/dl) N/A 2.1 2.0
Hemoglobin (g/dl) N/A 8.3 8.3
5 Creatinine (mg/dl) 1.2 5.1 5.5
Albumin (g/dl) 3.5 3.2 3.3
Hemoglobin (g/dl) 11.8 13.6 13.3
6 Creatinine (mg/dl) 2.6 6.5 5.4
Albumin (g/dl) 4.2 4.2 4.0
Hemoglobin (g/dl) 12.6 10.1 10.2
7 Creatinine (mg/dl) 1.3 11.2 11.0
Albumin (g/dl) 4.6 2.5 2.5
Hemoglobin (g/dl) 12.6 10.3 11.1
8 Creatinine (mg/dl) 1.4 4.7 4.7
Albumin (g/dl) 3.4 3.1 3.1
Hemoglobin (g/dl) 11.1 10.2 10.2
N/A = not available.
To convert creatinine to μmol/L, multiple by 88.4.
To convert albumin to g/L, multiple by 10.
To convert hemoglobin to g/L, multiple by 10.
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pretation of the data in the US Renal Data System regis-
try. The “primary etiology” of ESRD listed on the ESRD
Medical Evidence (CMS 2728) Form may not convey
the critical role of these episodes of rapid decline in kid-
ney function in precipitating the need for ESRD ther-
apy–e.g., in the example of Patient 3 at CPMC when
there was severe acute tubular necrosis superimposed
upon CKD due to diabetes mellitus. The traditional
approach of ascribing only one single cause for each
ESRD case in the American and other national registries
does not capture the complexity of clinical reality. In
addition, because of the existing data collection process,
current documentation in the US Renal Data System
may not accurately reflect the “pre-dialysis” health status
in a number of patients. The hemoglobin and albumin
at the start of dialysis as documented in the Medical
Evidence form has been used in prior studies to assess
quality of CKD care in the USA and to infer decisions
that are made by patients and physicians regarding tim-
ing of initiation of dialysis [9,10]. These analyses assume
that all dialysis patients had a slowly progressive CKD
course and that there were opportunities available to
treat the low hemoglobin level or to initiate dialysis
before hypoalbuminemia developed. This assumption
naturally does not hold in the cases where there are
superimposed episodes of rapid decline in kidney
function.
The strengths of this study include its emphasis on a
hitherto underappreciated aspect of the natural history
of transition from CKD to ESRD. We studied this issue
in two distinct health care settings which serve different
patient populations and this strengthened the external
validity of our conclusions. The clinical and public
health importance of highlighting this “cause” of ESRD–
affecting perhaps 5-10% of incident ESRD patients–
should be put into context of other ESRD etiologies. By
comparison, according to US Renal Data System, 3% of
ESRD are due to “cystic/heriditary/congential diseases”
and 2% to “secondary glomerulonephritis” (such as
lupus nephritis) [11].
Limitations of this study relate to its small sample size
which is partly due to the labor-intensive process of
conducting chart review. However, the level of granular-
ity achieved (down to exact day of initiation of acute
dialysis which then transitioned into maintenance dialy-
sis) may not be reliably replicated in administrative
databases in which the exact start of date of dialysis
may be documented with a margin of error of up to a
few months. The small sample size limited our ability to
conduct meaningful analyses regarding predictors of
rapid decline in kidney function or whether the post-
ESRD outcomes differed among patients who did and
did not suffer rapid decline in kidney function. Our
results are based on a two hospital affiliated dialysis
units in Northern California and so may not be general-
izable to other setting. The mean age and proportion of
male patients in our study sample were higher than the
general U.S. incident ESRD population. However, they
have face validity and are consistent with the clinical
experience of practicing nephrologists. Owing to the
limited sample sizes, numerous comparisons (Tables 1
and 2) did not achieve statistical significance, although it
seems unlikely that differences observed were merely
chance findings (e.g., the pre-test probability is high that
patients who develop acute kidney injury with non-
recovery of renal function would not have mature dialy-
sis fistulas in place). We were not able to access infor-
mation documented on the Medical Evidence (CMS
2728) Form for patients at one of the two dialysis units.
We had limited information about the setting in which
the rapid declines in kidney function occurred and
about the care provided to these patients (e.g. timing of
nephrology involvement). Our definition of “rapid
decline in kidney function” was arbitrary. We did not
use consensus definitions for acute kidney injury that
were developed more for hospitalized patients (especially
critically ill inpatients) [1] as we wanted to capture a
broader spectrum of rapid decline in renal function. But
we believe that our estimation of the magnitude of the
problem is conservative since we required documenta-
tion within three months of ESRD of a relatively high
prior estimated GFR value of 30 ml/min/1.73 m
2. Thus,
a patient who has had stable GFR at 25 ml/min/1.73 m
2
for several years before developing ESRD abruptly as a
result of severe acute tubular necrosis during a hospita-
lization would not have been counted; neither would a
patient who presented with rapidly progressive glomeru-
lonephritis without known prior serum creatinine mea-
surements in the hospital systems.
In summary, it appears that numerous cases of ESRD
are preceded by rapid declines in kidney function. The
importance of these periods of rapid decline in kidney
function has been under-appreciated in prior studies of
the natural history of CKD and ESRD.
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